Urine: Beyond cytology for detection of malignancy

Diagnostic Cytopathology

Volumn 27, Issue 3, 2002, Pages 139-142

  Pattari, Sanjib Kumar ^a   Dey, Pranab ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ancillary technique; Cytology; Pathology; Urine

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKERATIN 20; GELATINASE B; MATRIX METALLOPROTEINASE; NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; TELOMERASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER RECURRENCE; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; URINARY TRACT CARCINOMA; URINE CYTOLOGY;

ANTIGENS, NEOPLASM; CHORIONIC GONADOTROPIN; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; MATRIX METALLOPROTEINASES; NUCLEAR MATRIX-ASSOCIATED PROTEINS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0036727186     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10135     Document Type: Article

References (72)

1. Transitional cell carcinoma of the bladder: Diagnosis and prognosis
2. Urine sediment as a diagnostic procedure in cancers of the urinary tract
3. The sensitivity of bladder wash cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma
4. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma
5. Diagnostic accuracy of urinary cytology and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow up for bladder tumor
6. Comparison of bladder washings and urine in the diagnosis of bladder cancer
7. Exfoliative cytology of the urinary bladder irrigation specimen
8. The diagnostic value of urine versus bladder washing in patients with bladder cancer
9. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA cytometry consensus conference
10. Diagnostic accuracy of DNA image cytometry and urinary cytology with cell from voided urine in the detection of bladder cancer
11. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells
12. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma
13. Dual parameter immunoflow cytometry in diagnosis and follow up of patients with bladder cancer
14. Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors
15. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies
16. Results of a multicancer trial using the BTA test to monitor for and diagnose recurrent bladder cancer
17. BTA-TRAK combined with urinary cytology is a reliable urinary indicator of recurrent transitional cell carcinoma (TCC) of the bladder
18. Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer
19. Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: Comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladder
20. Identification of a nuclear protein matrix
21. Nuclear protein matrix: Association with newly synthesized DNA
22. The nuclear matrix: Defining structural and functional roles
23. The nuclear matrix and the regulation of gene expression: Tissue specificity
24. Pre mRNA splicing and the nuclear matrix
25. Mapping replicational sites in the eukaryotic cell nucleus
26. Nuclear matrix proteins reflect cell type and origin in cultured human cells
27. Use of a new tumor marker, urinary NMP-22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
28. Evaluation of NMP-22 in the detection of transitional cell carcinoma of the bladder
29. A sensitive cost effective test in patients at risk for bladder cancer
30. Urinary NM:-22™ and karyometry in the diagnosis and follow up of patients with superficial bladder cancer
31. Urinary nuclear matrix proteins as a marker for transitional cell carcinoma of the urinary tract
32. Matrix metalloproteinases, a review
33. Matrix metalloproteinase gene expression
34. Expression and localisation of matrilysis, a matrix metalloproteinase, in human endometrium during the reproductive
35. Expression of a metalloproteinase that degrades nature type V-collagen and denatured collagens by cultured human alveolar macrophages
36. Metalloproteinases and their inhibitors in matrix remodeling
37. Breast cancer associated stromolysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing
38. Wound fluid from chronic leg ulcers contains elevated travels of metalloproteinases MMP-2 and MMP-9
39. Collagen and collagenase: Pregnancy and parturition
40. Mechanism of mineral solubilisation and matrix degradation in osteoclastic bone resorption
41. Co-ordinated expression extracellular matrix degrading proteinases and their inhibitors regulates mammary epithelial function during involution
42. Metalloproteinases and cancer invasion
43. Ras oncogene mediated induction of a 92 kDa metalloproteinous strong correlation with the malignant phenotype
44. Augmentation of type IV collagenase, laminin receptor and ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression
45. Expression of gelatinolytic activity by oesophageal and colon carcinoma cell lines
46. Diversity of human pancreatic cancer cell proteinases: Role of cell membrane metalloproteinases in collagenolysis and cytolysis
47. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas
48. Carcinoma with trophoblastic differentiation and secretion of chorionic gonadotropins
49. Human chorionic gonadotrophin detected in urinary concentrates from patients with malignant tumours of the testis, prostate, bladder, ureter and kidney
50. Primary carcinoma of the urinary bladder in association with undifferentiated carcinoma
51. Primary carcinoma of the urinary bladder. Report of a case with probable epithelial origin
52. Immunohistochemical localization and chromatographic characterization of human chorionic gonadotrophin in bladder carcinoma
53. Expression and secretion of the beta subunit of human chorionic gonadotrophin by bladder carcinoma in vivo and in vitro
54. Expression of human chorionic gonadotrophin beta subunit genes in superficial and invasive bladder carcinomas
55. Free human chorionic gonadotrphin β subunit in gonadal and non gonadal neoplasms
56. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines
57. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer
58. Production of trophoblastic hormones by transitional cell carcinoma of the bladder. Association to tumor stage and grade
59. Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction
60. The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
61. Telomeres, telomerase and immortality
62. Specific association of human telomerase activity with immortal cells and cancer
63. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity
64. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine
65. Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma
66. Urinary telomerase and its possible role as a marker for bladder cancer
67. The catalog of human cytokeratins: Patterns of expression in normal epithelial tumors and cultured cell
68. Normal human urothelial cells in vitro: Proliferation and induction of stratification
69. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
70. Cytokeratin-20: A new marker for early detection of bladder cell carcinoma
71. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma
72. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma